Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EWG Sunscreen Assessment Finds Oxybenzone Use Slowing, But Shows Most Still Are ‘Inadequate’

May 06 2022

• By Eileen Francis

• Source: Alamy

Related Content

PCPC, CHPA Ask US FDA To Defer Final Rulemaking On Sunscreen Actives In GRASE Limbo

Jan 10 2022

On EU's Heels, UK Seeks Data On UV Filters Suspected Of Endocrine Disruption

Apr 13 2022

EWG Endorses Mineral Sunscreens, Avobenzone And UVA-Protective Chemicals Stranded In Europe

May 23 2020

National Toxicology Program: Oxybenzone Shows ‘Equivocal Evidence Of Carcinogenic Activity’

Oct 30 2019

FDA’s Proposed Order For Sunscreens, A First Under OTC Reforms, Reprises 2019 Proposed Rule

Sep 24 2021

EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments

Jan 23 2021

Additional Topics

International United States Cosmetics OTC Drugs Research & Development Advertising, Marketing & Sales Business Strategies Commercial Compliance Consumer Cosmetic Ingredients Drug Approval Standards FDA Ingredients Manufacturing Policy Politics Regulation Safety Dermatology Cancer

More from International

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window